Fundraising Fox

SymBio Pharmaceuticals

3 known investors

symbiopharma.com ↗

SymBio Pharmaceuticals develops and delivers prescription pharmaceuticals, providing product information on its medical drugs to healthcare professionals in Japan.

BiotechHealthtech

Investors · 3

DBJ CapitalTokyo · $2.7M – $354M
Nippon Venture CapitalTokyo · $1.5M – $269M
SMBC Venture CapitalTokyo · $2.3M – $269Mvia Hiroya Ota · inferred

In the news

SymBio’s First-Half Loss Deepens as Equity Turns Negative - TipRanks.comtipranks.com · Aug 2026SymBio Pharmaceuticals Limited announced that it expects to receive ¥600 million in funding from Cantor Fitzgerald Europe -December 24, 2024 | MarketScreenermarketscreener.com · Dec 2024SymBio Pharmaceuticals Successfully Completes JPY2.0 Billion (USD24 Million) Series E Private Placement | Fierce Biotechfiercebiotech.com · Feb 2011

Frequently asked questions

What does SymBio Pharmaceuticals do?
SymBio Pharmaceuticals develops and delivers prescription pharmaceuticals, providing product information on its medical drugs to healthcare professionals in Japan.
Who are SymBio Pharmaceuticals's investors?
SymBio Pharmaceuticals's investors include DBJ Capital, Nippon Venture Capital, SMBC Venture Capital.